Chemoprevention in Breast Cancer-Reference-Cited by-同舟云学术

Chemoprevention in Breast Cancer

Published:2021 Issue: Volume: Page:338-354
ISSN:2475-6628
Container-title:Handbook of Research on Oncological and Endoscopical Dilemmas in Modern Gynecological Clinical Practice
language:
Short-container-title:

Author:

Nikiforou-Lialiampidou Marianna¹,Moga Marius²,Kalder Matthias³,Pratilas George-Chrysostomos⁴,Dinas Konstantinos⁴

Affiliation:

1. Department of Psychiatry, Aristotle University of Thessaloniki, Greece

2. Clinic Department of Obstetrics and Gynecology, Faculty of Medicine, Transilvania University of Brasov, Romania

3. Department of Obstetrics and Gynaecology, Philipps-University of Marburg, Germany

4. 2nd Department of Obstetrics and Gynaecology, Aristotle University of Thessaloniki, Greece

Abstract

Chemoprevention in breast cancer represents one of the most important therapeutic regimens in an effort to optimize survival and prevent breast cancer recurrence. The chapter aims to analyze below all potential medical regimens used in breast cancer chemoprevention, along with explaining the reasons why those are the ones selected: their characteristics, their mechanism of action, and their side effects. Among these, we may report tamoxifen, raloxifen, aromatase inhibitors, and new therapeutic regimens such as polyphenoles.

Publisher

IGI Global

Reference30 articles.

1. Sowing the Soil for Cure? Results of the ABCSG-12 Trial Open a New Chapter in the Evolving Adjuvant Bisphosphonate Story in Early Breast Cancer

2. Current concepts in breast cancer chemoprevention. Polish;R. T.Chlebowski;Archives of Internal Medicine,2014

3. Oral Bisphosphonate Use and Breast Cancer Incidence in Postmenopausal Women

4. Regular and low-dose aspirin, other non-steroidal anti-inflammatory medications and prospective risk of HER2-defined breast cancer: the California Teachers Study

5. Metformin inhibits the development, and promotes the resensitization, of treatment-resistant breast cancer